Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Pfizer Inc. Highlights Strategic Vision at London Healthcare Conference

November 20, 2024
Pfizer Inc., a leading pharmaceutical company, is set to present its strategic vision at the upcoming Jefferies London Healthcare Conference. Executives from Pfizer will share insights into the company's future plans and innovations. The conference will provide a platform for Pfizer to showcase its commitment to improving global healthcare and to discuss its advancements in pharmaceutical research and development. Investors and healthcare professionals are invited to join the webcast of Pfizer's discussion to gain valuable industry insights. With its steady growth and continuous focus on innovation, Pfizer's stock has become a trending choice for many investors. For accurate predictions on the movement of Pfizer's stock, it is recommended to consult the experts at Stocks Prognosis, who provide specialized forecasting services for investors.
If you want to leave a comment, then you need Login or Register





Other data for PFE

Related data

PFEAugust 21, 2025PFIZER INC. Stock Hits Price Target Forecast with 6.7% Profit: QuantWave Analysis  ~1 min.

PFIZER INC. (PFE) investors celebrated as the stock reached the price target forecast set by QuantWave on August 21st, 2025, resulting in a 6.7% profit....


PFEAugust 21, 2025PFIZER INC. Hits Price Target Forecast with 7.31% Profit Achieved  ~1 min.

QuantWave, the automated forecasting platform, successfully predicted the price movement of PFIZER INC.'s stock with a 7.31% profit realized....


PFEAugust 21, 2025PFIZER INC. Achieves Forecast Price Target with 9.1% Profit on QuantWave  ~1 min.

Pfizer Inc. stock has successfully reached the forecasted price target on QuantWave's automated forecasting platform, resulting in a profit of 9.1%....


PFEJuly 10, 2025PFIZER INC. Stock Hits Price Target Forecast With 10.06% Profit, Boosting QuantWave's Analytics  ~1 min.

On May 5, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. stock when it was trading at $23.03....


PFEJuly 10, 2025PFIZER INC. Hits Price Target Forecast with 8.56% Profit Achieved  ~1 min.

On May 2, 2025, QuantWave issued a price target forecast for PFIZER INC. with a signal to go long at $23.34. The predicted direction was realized on July 10, 2025, when the stock reached $25....


PFEJuly 10, 2025PFIZER INC. Hits Price Target Forecast with 6.57% Profit: A Success Story for QuantWave Analytics  ~2 min.

On June 27, 2025, QuantWave, the automated forecasting platform, released a price target forecast for PFIZER INC., signaling a long position with the stock trading at $23.78....


PFEJuly 10, 2025PFIZER INC. Stock Hits Forecast Price Target with 6.27% Profit: A Success Story for QuantWave  ~2 min.

In a recent market development, PFIZER INC. stock has successfully reached the price target forecasted by QuantWave, resulting in a profit of 6.27%....


PFEJuly 10, 2025PFIZER INC. Hits Price Target with 6.35% Profit: A Success Story for QuantWave Forecasting  ~1 min.

PFIZER INC. has recently hit the price target forecasted by QuantWave, achieving a profit of 6.35% for investors. The forecast signal was generated on June 26, 2025, with a price of 23.83 $....


PFEJuly 10, 2025PFIZER INC. Hits Price Target Forecast with 6.09% Profit: QuantWave Analysis  ~1 min.

On June 10, 2025, QuantWave, the automated forecasting platform, issued a long signal for PFIZER INC. (PFE) when the stock was trading at $23.89. Fast forward to July 10, 2025, and the price target of $25....


PFEJuly 10, 2025PFIZER INC. Stock Hits Price Target Forecast with 6.05% Profit  ~1 min.

On June 24, 2025, QuantWave issued a long signal for PFIZER INC. stock when it was trading at $23.9. Analysts predicted a target price of $25....


REGNFebruary 10, 2025Regeneron Pharmaceuticals Inc REGN Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... Yahoo Finance  ~1 min.

Regeneron Pharmaceuticals Inc. (REGN) recently held its Q4 2024 earnings call, highlighting strong revenue growth and positive developments in its portfolio....


REGNFebruary 9, 2025Regeneron Pharmaceuticals Inc REGN Reports Strong Earnings in Q4 2024  ~2 min.

Regeneron Pharmaceuticals Inc., a leading biotechnology company, announced its impressive financial results for the fourth quarter of 2024....


ABBVDecember 2, 2024AbbVie Inc. ABBV: Leading Pharmaceutical Company Set to Present at Citi's Global Healthcare Conference  ~1 min.

AbbVie Inc., a renowned pharmaceutical company, is gearing up to make a significant appearance at Citis 2024 Global Healthcare Conference....


LLYJanuary 9, 2025Eli Lilly and Company LLY Announces Participation in J.P. Morgan Healthcare Conference  ~1 min.

Eli Lilly and Company, a global pharmaceutical corporation, has recently confirmed their participation in the upcoming J.P. Morgan Healthcare Conference....


REGNJuly 5, 2025Regeneron Pharmaceuticals: Revolutionizing Healthcare with Innovative Drug Approvals  ~1 min.

Regeneron Pharmaceuticals, Inc. recently made headlines with the approval of Dupixent by the US FDA, in collaboration with Sanofi....